Characterization of Clinical MRSA Isolates from Northern Spain and Assessment of Their Susceptibility to Phage-Derived Antimicrobials.
Marina SalasMaciej WerneckiLucía FernándezBeatriz IglesiasDiana GutiérrezAndrea ÁlvarezLaura GarcíaElisabeth PrietoPilar GarcíaAna RodríguezPublished in: Antibiotics (Basel, Switzerland) (2020)
Methicillin-resistant Staphylococcus aureus (MRSA) is a prevalent nosocomial pathogen, causing a wide range of diseases. The increased frequency of MRSA isolates in hospitals and the emergence of vancomycin resistance have sparked the search for new control strategies. This study aimed to characterize sixty-seven MRSA isolates collected from both infected patients and asymptomatic carriers in a Spanish hospital. RAPD-PCR allowed the identification of six genetic patterns. We also investigated the presence of genes involved in producing adhesins, toxins and the capsule; the biofilm; and antimicrobial resistance. A notable percentage of the isolates carried virulence genes and showed medium-high ability to form biofilms. Next, we assessed the strains' susceptibility to two phages (phiIPLA-C1C and phiIPLA-RODI) and one endolysin (LysRODI). All strains were resistant to phiIPLA-C1C, and most (70.2%) were susceptible to phiIPLA-RODI. Regarding LysRODI, all strains displayed susceptibility, although to varying degrees. There was a correlation between endolysin susceptibility and the random amplification of polymorphic DNA (RAPD) profile or the presence of some virulence genes (fnbA, eta, etb, PVL and czr), but that was not observed with biofilm-forming ability, strain origin or phage sensitivity. Taken together, these findings can help to explain the factors influencing endolysin effectiveness, which will contribute to the development of efficient therapies targeting MRSA infections.
Keyphrases
- methicillin resistant staphylococcus aureus
- staphylococcus aureus
- pseudomonas aeruginosa
- antimicrobial resistance
- escherichia coli
- biofilm formation
- candida albicans
- genome wide
- healthcare
- cystic fibrosis
- bioinformatics analysis
- randomized controlled trial
- genetic diversity
- acinetobacter baumannii
- gene expression
- single molecule
- nucleic acid
- cell free
- cancer therapy
- klebsiella pneumoniae
- mass spectrometry
- high resolution
- high speed
- adverse drug
- neural network
- transcription factor
- real time pcr